Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 5 Low-Debt Biotech Stocks Forecasted For Growth
5 Low-Debt Biotech Stocks Forecasted For Growth
5 Low-Debt Biotech Stocks Forecasted For Growth
Submitted by
admin
on September 22, 2012 - 2:24pm
Source:
Seeking Alpha
News Tags:
Merrimack Pharmaceuticals
Durata Therapeutics
BioSpecifics Technologies
Pain Therapeutics
Acadia
Headline:
5 Low-Debt Biotech Stocks Forecasted For Growth
Do Not Allow Advertisers to Use My Personal information
